‘Contactless’ COVID-19 Trial to Test Common Anti-Inflammatory Drug

UC SFis recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.